RxSight, Inc. (RXST) analyst actions
Rating and price-target actions on RXST in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the RXST overview →
9 measured RXST analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook | Press release | +2.82% | -6.60% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out | Press release | — | +0.00% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out | Press release | -0.63% | -1.88% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out | Press release | -0.69% | +1.15% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out | Press release | -1.00% | -4.63% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out | Press release | -0.24% | -1.10% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out | Press release | -0.23% | +0.34% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out | Press release | -0.29% | +0.81% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out | Press release | -1.21% | +2.96% |
Keep exploring
More RXST: earnings → · SEC filings → · RXST overview →